CIPO Patents = 2

EPO Patents = 4

Forward Citations = 90

Loading Chart...

2 inventors (with patents filed for the assignee):

Rashida A Karmali (9 out of 19 patents)

Felix Wehrmann (1 out of 7 patents)

9 patents: Sort by Forward Citations

1. 8802831 - Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt (2014-08-12),

2. 8415388 - Pharmaceutical compositions containing paclitaxel orotate (2013-04-09),

3. 8148339 - Method of reducing cardiac levels of doxorubicin when given as orotate salt (2012-04-03),

4. 8034823 - Method of increasing drug oral bioavailability and compositions of less toxic orotate salts (2011-10-11),

5. 7601834 - Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives (2009-10-13),

6. 7470672 - Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives (2008-12-30),

7. 7378054 - Specimen collecting, processing and analytical assembly (2008-05-27),

8. 6239137 - Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity (2001-05-29),

9. 6184227 - Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases (2001-02-06),

Company Overview

Savvipharm Inc is a pharmaceutical company that specializes in developing innovative medications to improve patient outcomes. With a focus on research and development, Savvipharm Inc aims to create cutting-edge therapeutics for a wide range of medical conditions. Their commitment to excellence and dedication to advancing healthcare make them a leading player in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#762 in New York, NY

#1,901 in New York

#32,565 in US

New York, NY, United States of America

Savvipharm Inc

Forward Citations = 90

2 inventors:

Rashida A Karmali (9 out of 19 patents)

Felix Wehrmann (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Savvipharm Inc. Retrieved from https://idiyas.com/company/savvipharm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]